Cobalt-dependent ribonucleotide reductase: a drug target

Applied bioinorganic chemistry sits where metal centres, biological pathways and therapeutic decisions meet. The 16th International Symposium on Applied Bioinorganic Chemistry (ISABC), held in Ioannina, Greece, in June 2023 and organised by the University of Ioannina, gave researchers a forum for translating molecular insights into useful interventions. Its discussions connected mechanisms, experimental methods and therapeutic applications.

Among the themes with clinical leverage was cobalt-dependent ribonucleotide reductase (CoRNR), a bacterial enzyme that uses a cobalamin, or vitamin B12, cofactor to support DNA synthesis. Its radical relay is intricate enough to fascinate a spectroscopist, while the absence of this machinery from human cells offers a possible selectivity advantage for antibacterial design. The target has real promise, but promising biology still needs rigorous chemistry, delivery and resistance studies.

That proposition resonates in Australia, where antimicrobial resistance is a national research priority and the National Health and Medical Research Council, Australian Research Council and Medical Research Future Fund shape collaborations between universities, hospitals and industry. Melbourne and Sydney host established biotech and pharmaceutical clusters, while CSIRO and campus laboratories add expertise in microbiology, chemistry and imaging. Local programmes often depend on partnerships across these sectors, so a validated bacterial target can be attractive to teams seeking a focused route from fundamental chemistry to translation.

ISABC provided a setting for that exchange. Official symposium information covers participation, young scientist travel awards, poster prizes, scholarships and application requirements, with Zita Congress & Event Management as the secretariat for registration, accommodation and abstract-related enquiries. Ioannina’s academic setting made the meeting a bridge between laboratory evidence and the wider European bioinorganic community. Australian delegates could bring disease-relevant questions and perspectives from a research system that is internationally connected but geographically spread.

A bacterial enzyme with therapeutic potential

CoRNR is a class II ribonucleotide reductase found in many bacteria. It reduces ribonucleotide diphosphates to deoxyribonucleotides, the building blocks needed for DNA replication. An adenosylcobalamin cofactor participates in a controlled radical relay that supports formation of the substrate radical. The enzyme therefore combines two strategically important features: metal-assisted chemistry and a pathway central to bacterial genome maintenance.

The therapeutic logic depends on selectivity. Human ribonucleotide reductase belongs to a different enzyme class and does not rely on this cobalt-dependent machinery, creating a potential biochemical window. Bacterial species are not uniform: some carry class I or alternative reductases, and resistance can emerge through altered uptake, bypass of the blocked step or replacement of the cofactor pathway. A strong programme must therefore test target prevalence and redundancy alongside potency.

Metal cofactors and radical chemistry

Inhibitor design requires more than occupying the active site. A compound might interfere with cobalamin handling, interrupt radical transfer or exploit pathogen-specific protein features. Structural biology, transient absorption and EPR spectroscopy, isotope labelling and biochemical redox assays each reveal a different layer of the mechanism. Shared platforms at Australian universities and CSIRO teams can connect these methods, while industry partners contribute assay development and medicinal chemistry.

Multimethod testing is essential because a weak biochemical signal can disappear inside living cells. Whole-cell studies should check growth inhibition, bactericidal activity, cytotoxicity and recovery after exposure. Australian teams working with hospital isolates can add clinically relevant strains, provided that biosafety, containment and strain governance are planned from the outset. This produces a more defensible profile for grant applications and partnering.

From target validation to Australian pipelines

Translational progress usually follows a ladder: confirm the enzyme is essential, establish chemical matter that binds it, improve potency and selectivity, and show exposure at the site of action. The ladder is familiar to Australian drug-discovery groups, where university spin-outs and biotech companies in Melbourne, Sydney, Brisbane and Adelaide often work with global pharmaceutical partners. CoRNR could support an antibiotic strategy, although development still requires a manufacturable molecule, scalable formulation and clinical pathway.

Biomedical context matters too. Microbial chemistry can influence host physiology beyond the original enzyme, including links between the microbiome, inflammation and respiratory outcomes. A broader reading of the gut-lung axis illustrates why translation teams should consider both microbial function and the human environment in which medicines act. This is not evidence that CoRNR controls that axis; it is a reminder to separate a target’s direct mechanism from downstream biology when building a development case.

Conferences as engines of collaboration

The value of ISABC lay in the people around the chemistry. In Ioannina, delegates could move from a lecture on metal binding to a poster on pathogen biology, then discuss which assay should come next. Young scientist travel awards and poster prizes supported early-career visibility, while scholarships offered further support for participation. These routes are valuable for Australian teams seeking international visibility without treating a conference trip as an isolated event.

Not everyone finds a crowded conference room an easy place to work. For delegates who prefer a quieter start, the symposium’s networking tips for introverts offer a sensible way to turn a hallway encounter into a useful exchange. Australian lab culture is comfortable with “postdoc” and “PI,” but a friendly “g’day” and a precise question can still open a substantial conversation. Poster sessions, scheduled chats and shared transport offer low-pressure ways to meet collaborators.

A practical route for research teams

Teams preparing for ISABC should begin with one question: which part of CoRNR biology will they test, and what evidence would move it forward? A concise abstract can focus on metal-cofactor chemistry, inhibitor synthesis, structural analysis, resistance mechanisms or a validated cellular assay. Check the official application requirements early, especially when a poster prize, travel award or scholarship is involved. Supervisors can use a presentation as a milestone for a student or early-career researcher to define a result and identify the next collaboration.

Zita Congress & Event Management can assist with registration, accommodation and abstract-related enquiries, which helps when coordinating a trip from Australia to Ioannina. Plan time zones, funding approvals and visa requirements well ahead; although the June meeting falls in Australia’s winter, long-haul travel can still be tiring. After the meeting, a short internal debrief can capture contacts, assay gaps and follow-up actions. That discipline turns a conference presentation into part of a development pathway.


ISABC offered a timely place to connect cobalt chemistry with the global need for new antibacterial strategies. For the symposium community, the next step is to turn mechanistic insight into reproducible assays, credible selectivity data and collaborations capable of carrying a candidate forward. The official symposium information and Zita Congress & Event Management are the practical points of contact for participation, awards, abstracts, registration and accommodation.

Researchers in Australia and elsewhere can use ISABC to bring fresh questions to Ioannina and take a stronger case for CoRNR back to their laboratories. Review the symposium materials, submit an abstract or application where relevant, and contact the secretariat to plan a productive visit.